Novo Nordisk celebrates first ever UN-observed World Diabetes Day

Novo Nordisk14 November is World Diabetes Day (WDD). This year is the first time that WDD is officially recognised by the United Nations. Novo Nordisk is celebrating the day with activities all over the world, from the UN building in New York to the pyramids of Egypt.

In New York, Novo Nordisk is arranging an event around the Changing Diabetes Bus, which has travelled across five continents since September 2006. And in Cairo, Novo Nordisk's Egyptian affiliate will organize diabetes walks by the pyramids and launch their own Changing Diabetes Bus.

Furthermore, Novo Nordisk will conduct special events in seven other cities: Beijing (China), Copenhagen (Denmark), Havana (Cuba), London (UK), Paris and Strasbourg (France). Here there will be Global Diabetes Walks, which put focus on an active lifestyle, human blue circles (to illustrate the UN symbol) and other external events.

"The adoption of the UN Resolution on diabetes demonstrates that all nations have recognised the severity of this worldwide pandemic. However, our engagement doesn't stop here. We have committed to work actively to help implement the Resolution on a national level by for instance continuing the Changing Diabetes Bus world tour into 2008. We will also establish high-level groups of experts to explore practical ways of improving diabetes care" says Lars Rebien Sørensen, president and CEO of Novo Nordisk.

Diabetes is a silent killer that can affect anyone at any time and is causing devastating global consequences. In 2007 diabetes is expected to cause 3.8 million deaths worldwide, almost as much as HIV/AIDS. Today 246 million people have diabetes and by 2025, the figure is expected to reach 380 million. If the trend continues at this pace diabetes will be the worst pandemic the world has ever seen by 2025.

The Resolution on diabetes was adopted by the United Nations on 20 December 2006.

For further details, please visit the World Diabetes Day website:
http://diabetesbus.novonordisk.com/Diabetes/
Diabetes-Bus/World-Diabetes-Day/world-diabetes-day-default.asp

About Novo Nordisk
Novo Nordisk is a healthcare company and a world leader in diabetes care. The company has the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems. In addition, Novo Nordisk has a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society. With headquarters in Denmark, Novo Nordisk employs approximately 25,800 employees in 79 countries, and markets its products in 179 countries. Novo Nordisk's B shares are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed on the New York Stock Exchange under the symbol 'NVO'. For more information, visit www.novonordisk.com.

Most Popular Now

GSK reaches agreement with Novartis to acquire ful…

GlaxoSmithKline plc (LSE/NYSE: GSK) today announces that it has reached an agreement with Novartis for the buyout of Novartis' 36.5% stake in their Consumer Healthcare Jo...

Canadian neuroscientists say daily ibuprofen can p…

A Vancouver-based research team led by Canada's most cited neuroscientist, Dr. Patrick McGeer, has successfully carried out studies suggesting that, if started early enou...

Merck partners with Medisafe to help improve medic…

Merck, a leading science and technology company, today announced a new collaboration with US-based Medisafe to help its cardiometabolic patients better manage medication ...

New immunotherapy for lung cancer shows promise of…

In a groundbreaking development, results from a recent clinical trial to treat lung cancer show that a novel immunotherapy combination is surprisingly effective at contro...

Boehringer Ingelheim and OSE Immunotherapeutics an…

Boehringer Ingelheim and OSE Immunotherapeutics, a biotechnology company focused on the development of innovative immunotherapies, have announced a collaboration and excl...

Personalized tumor vaccine shows promise in pilot …

A new type of cancer vaccine has yielded promising results in an initial clinical trial conducted at the Perelman School of Medicine at the University of Pennsylvania and...

Taking a standard prostate cancer drug with food b…

By taking a high-cost drug with a low-fat meal - instead of on an empty stomach, as prescribed - prostate cancer patients could decrease their daily dose, prevent digesti...

New targeted therapy schedule could keep melanoma …

Skin melanoma, a particularly insidious cancer, accounts for the vast majority skin cancer deaths and is one of the most common cancers in people under 30. Treatment for ...

Researchers identify chemical compound that inhibi…

An organic chemical compound shows effective antiviral activity against Ebola virus and several other viruses, according to a study led by Georgia State University. The r...

When drugs are wrong, skipped or make you sick: Th…

Rising drug prices have gotten a lot of attention lately, but the actual cost of prescription medications is more than just the dollars and cents on the bill. Researchers...

New class of drugs could help tackle treatment-res…

Researchers have discovered a new class of drug that has the potential to help cancer patients who no longer respond to existing therapies. The drug may not become availa...

Researchers propose key elements of antimicrobial …

Antimicrobial stewardship programs (ASPs) in hospitals play a vital role in managing the threat of antibiotic resistance. To be of maximum effectiveness, essential elemen...